This study is not yet accepting patients
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by Khaled Moussawi, MD, PhD (ucsf)
Description
Summary
Details
Keywords
Eligibility
Location
Lead Scientist at University of California Health
- Khaled Moussawi, MD, PhD (ucsf)
The Translational Neuropsychiatry Through Neuromodulaton (TN²) laboratory investigates the neurobiology of substance use disorders and uses neuromodulation tools such as Low-Intensity Focused Ultrasound (LIFU), Transcranial Magnetic Stimulation (TMS), and Deep Brain Stimulation (DBS) to treat drug and alcohol addiction and related neuropsychiatric disorders.
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT06518785
- Study Type
- Interventional
- Participants
- Expecting 25 study participants
- Last Updated